Advertisement
News
Subscribe to MDT Magazine News

Tylenol 8 Hour Caplets 50 Count: Recall

October 19, 2010 12:35 pm | by U.S. Food & Drug Administration | Comments

Uncharacteristic musty or moldy odor.

Mylan Declares Quarterly Preferred Stock Dividend

October 19, 2010 12:33 pm | by Bio-Medicine.Org | Comments

PITTSBURGH, Oct. 19 /- Mylan Inc. (Nasdaq: MYL ) today announced that in accordance with its 2.139 million preferred stock issuance, the company has declared its quarterly dividend of $16.25 per share (based on the annual dividend rate of 6.5% and a liquidation preference of $1,000.00 per...

TOPICS:

Reportlinker Adds Lung Cancer Drug Futures

October 19, 2010 12:33 pm | by Bio-Medicine.Org | Comments

NEW YORK, Oct. 19 /- Reportlinker.com announces that a new market research report is available in its catalogue: Lung Cancer Drug Futures http://www.reportlinker.com/p0315763/Lung-Cancer-Drug-Futures.html AN EXCEPTIONALLY COST EFFECTIVE SERVICE INCLUDING FORMATS TO MEET EVERY INFORMATION...

TOPICS:
Advertisement

Reportlinker Adds Prostate Cancer Drug Futures

October 19, 2010 12:33 pm | by Bio-Medicine.Org | Comments

NEW YORK, Oct. 19 /- Reportlinker.com announces that a new market research report is available in its catalogue: Prostate Cancer Drug Futures http://www.reportlinker.com/p0315764/Prostate-Cancer-Drug-Futures.html AN EXCEPTIONALLY COST EFFECTIVE SERVICE INCLUDING FORMATS TO MEET EVERY...

TOPICS:

Reportlinker Adds Global Top 10 Health Care Equipment Companies - Industry, Financial and SWOT Analysis

October 19, 2010 12:33 pm | by Bio-Medicine.Org | Comments

NEW YORK, Oct. 19 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Top 10 Health Care Equipment Companies - Industry, Financial and SWOT Analysis...

TOPICS:

PMA Final Decisions for September 2010(2)

October 19, 2010 12:31 pm | by U.S. Food & Drug Administration | Comments

These are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions for September 2010.

TOPICS:

PMA Final Decisions for September 2010

October 19, 2010 12:30 pm | Comments

These are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions for September 2010.

Patient dies in Biogen MS drug trial

October 19, 2010 11:32 am | by Mass High Tech: The Journal of New England Technology | Comments

In a Phase 2 clinical trial, Biogen Idec and Roche reported their multiple sclerosis treatment, ocrelizumab, showed signs of reducing the disease indications – but they also reported that one patient died during the testing.

TOPICS:
Advertisement

Patient Experience Research Grants Awarded

October 19, 2010 11:31 am | by Bio-Medicine.Org | Comments

DALLAS, Oct. 19 /- As part of its commitment to supporting efforts to improve the patient experience in healthcare, The Beryl Institute has awarded $1,000 grants to ten health care organizations that are exploring effective methods for addressing patient experience issues. (Logo:...

TOPICS:

Professional sports persons should drink more water

October 19, 2010 10:35 am | by EurekAlert | Comments

(FECYT - Spanish Foundation for Science and Technology) Top sports persons must always perform to their maximum capacity, making them the most vulnerable to the effects of dehydration. Now, a new study conducted by researchers from the Universidad de Castilla la Mancha reveals that...

TOPICS:

Cubist makes $250M notes offer

October 19, 2010 10:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Cubist Pharmaceuticals Inc. has announced it will offer up to $250 million aggregate principal amount of its convertible senior notes due 2017.

Healthcare IT firm Carrot Medical raises $1M

October 19, 2010 10:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Carrot Medical LLC, a Boston-based company develops communications systems in healthcare, has raised $1.1 million in an equity offering.

BioMolecular Therapeutics, a New Global Player in RNAi Therapeutics, Launches Company and Adds Key Advisors

October 19, 2010 10:33 am | by Bio-Medicine.Org | Comments

SEOUL, South Korea, Oct. 19 /- BioMolecular Therapeutics, Inc. (BMT, Inc.), a new Seoul-based RNAi therapeutics company with a proprietary technology designed to reduce significantly deleterious side effects triggered by conventional siRNA, announced that it has launched its global...

TOPICS:

LifePort Inc. Signs Two Agreements Launching Company Into Mission-Specific Seating

October 19, 2010 10:33 am | by Bio-Medicine.Org | Comments

ATLANTA, Oct. 19 /- NBAA Trade Show -- LifePort Inc. today announced the signing of two agreements that launch the company into customized mission-specific seating. LifePort is a Sikorsky Aerospace Services (SAS) company – the aftermarket division of Sikorsky Aircraft Corp., a...

TOPICS:

Celsion Announces ThermoDox's Prominence in Abstracts Presented at the 2nd International MR-Guided Ultrasound Symposium

October 19, 2010 10:33 am | by Bio-Medicine.Org | Comments

COLUMBIA, Md., Oct. 19 /- Celsion Corporation (Nasdaq: CLSN ) announced today that two abstracts on the ThermoDox® High Intensity Focused Ultrasound (HIFU) development program have been delivered via oral presentation at the MR-guided Focused Ultrasound 2010 2nd International...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading